Zacks Small Cap Research on MSN3h
MTVA: Phase 1 Part 2 Data for DA-1726 in Obesity Expected Soon…(NASDAQ:MTVA) is currently conducting a Phase 1 clinical trial of DA-1726 in patients with obesity. In September 2024, ...
JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.
A decade after the first introduction of angiography-derived fractional flow reserve (FFR), we are now entering an era in which simplified image-derived solutions could replace invasive assessment ...
Q4 2024 Earnings Conference Call March 28, 2025 10:30 AM ETCompany ParticipantsLinda Biles - Executive Vice President ...
R Street Responds: DATA Whitepaper Unhelpful in Discerning Causes of Transmission Development Delays
Whitepaper: “Recent Experience with Competitive Transmission Projects and Solicitations,” DATA: Developers Advocating ...
Q4 2024 Earnings Call Transcript March 26, 2025 MicroVision, Inc. misses on earnings expectations. Reported EPS is $-0.14 EPS ...
This score calculates overall vulnerability severity from 0 to 10 and is based on the Common Vulnerability Scoring System (CVSS). Attack Vector: This metric reflects the context by which vulnerability ...
This score calculates overall vulnerability severity from 0 to 10 and is based on the Common Vulnerability Scoring System (CVSS). Attack Vector: This metric reflects the context by which vulnerability ...
The GDPR sets out detailed requirements for companies and organisations on collecting, storing and managing personal data. It applies both to European organisations that process personal data of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback